Correction to "New Pathway for Cisplatin Prodrug to Utilize Metabolic Substrate Preference to Overcome Cancer Intrinsic Resistance".
Akil A KalathilSubham GuinAkash AshokanUttara BasuBapurao SurnarKatiana S DelmaLeonor M LimaOleksandr N KryvenkoShanta DharPublished in: ACS central science (2023)
[This corrects the article DOI: 10.1021/acscentsci.3c00286.].